Moreover, the level of PD‐1 expression on CD8+ T cells in peripheral blood may serve as a potential biomarker for identifying tumour‐infiltrating CD8+ T cells in HCC patients, which express various immune checkpoint receptors.198. The gene discussed is CD8A; the disease is hepatocellular carcinoma.